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Enteroaggregative Escherichia coli (EAEC) is frequently isolated from sporadic cases
of diarrhea and in outbreaks of gastroenteritis in several regions of the world. The
pathophysiology of EAEC continues to be enigmatic, and the efficacy of antibiotic
treatment in EAEC-associated diarrhea has been discussed. Since the level of antibiotic
resistance is increasing, it is essential to restrict the use of antibiotics to prevent further
resistance development. We aimed to investigate EAEC strains in adult Danish patients
suffering from diarrhea and from healthy controls. We examined the antibiotic resistance
in EAEC strains, the clinical response to antibiotic treatment in EAEC diarrheal cases,
and the distribution of virulence genes in diarrheal cases. The EAEC strains were
collected from patients suffering from diarrhea in a Danish multicenter study. A medical
doctor interviewed the patients by using a questionnaire regarding gastrointestinal
symptoms, exposures, and use of antibiotic and over-the-counter antidiarrheal drugs.
Follow-up was performed after 3–5 months to inquire about differential diagnosis to
gastrointestinal disease. A multiplex polymerase chain reaction characterized virulence
genes in diarrheal cases. Finally, the level of antibiotic resistance was examined by
using the disc diffusion method. Asymptomatic carriage of EAEC in the adult Danish
population was rare, in contrast to findings in healthy Danish children. The duration of
diarrhea was not shortened by antibiotic treatment, specifically ciprofloxacin treatment,
or by over-the-counter antidiarrheal drugs. Follow-up revealed no pathology in diarrheal
patients apart from irritable bowel syndrome in two patients. A high number of patients
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suffered from long-term diarrhea, which was associated with the enterotoxin EAST-1 and
a high virulence factor score. A high level of antibiotic resistance was observed and 58%
of the EAEC strains were multidrug resistant. Multidrug resistance was most pronounced
in cases of travelers’ diarrhea, and it was seen that antibiotic treatment did not reduce
the duration of diarrhea.
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INTRODUCTION
Enteroaggregative Escherichia coli (EAEC) has been associated
with persistent diarrhea in both children and adults (Bhan et al.,
1989; Schultsz et al., 2000). However, the contributing EAEC
virulence factors to this disease manifestation do not point out
to one specific virulence factor. The EAEC has proved to consist
of considerable genetic diversity and is believed to comprise
pathogenic as well as nonpathogenic strains (Jenkins et al., 2006).
A high proportion of asymptomatic carriage in children has
been reported in several studies (Nataro et al., 2006; Nüesch-
Inderbinen et al., 2013), yet very few studies have examined
EAEC carriage in adults.
The EAEC is characterized by its aggregative adherence
fimbriae (AAFs) that enable the bacteria to adhere to the
intestinal epithelium and form a persistent biofilm. The EAEC
is described as a very heterogeneous group with respect to its
virulence genes and their regulation (Hebbelstrup Jensen et al.,
2014).
The transcriptional activator AggR, involved in regulation
of at least 44 genes, both plasmid-borne and chromosomally
positioned, regulates expression of the AAF genes. The genes
aagR, aap (codes for dispersin), and aatA (ABC transporter)
are used for initial detection of EAEC, as is the chromosomal
gene aaiC, which encodes a type VI secretion system (Sheikh
et al., 2002; Dudley et al., 2006; Hebbelstrup Jensen et al., 2014).
Nevertheless, there is no consensus regarding which EAEC genes
are explicitly pathogenic.
Once adherence and biofilm formation are established,
EAEC pathogenesis usually involves the release of toxins,
and, particularly, serine protease autotransporters of the
Enterobacteriaceae (SPATEs) are commonly found in EAEC
strains. These include toxins such as Pet, Sat, SigA, SepA, and
Pic, which can be involved in loosening of cellular tight junctions,
mucosal damage, and hypersecretion, and promotion of biofilm
formation (Navarro-García et al., 1999; Navarro-Garcia et al.,
2010; Al-Hasani et al., 2000; Guyer et al., 2002; Coron et al.,
2009).
The EAEC was originally characterized from Chilean
children with diarrhea (Nataro et al., 1987), and is probably
best known for its role in persistent childhood diarrhea
in developing countries. However, EAEC is also commonly
associated with travelers’ diarrhea, and the English Intestinal
Infectious Diseases Study recognized foreign travel as the risk
factor most commonly associated with EAEC-related diarrhea
in 2000 (Infectious Intestinal Disease Study Team, 2000;
Mendez Arancibia et al., 2009; Hebbelstrup Jensen et al.,
2014).
Antibiotic resistance and, especially, multidrug resistance
(MDR) is of global concern, and the limitation of antibiotic
usage is crucial. For EAEC, a high level of antibiotic resistance
has been described previously (Sang et al., 1997; Khoshvaght
et al., 2014; Hebbelstrup Jensen et al., 2016). Extended-spectrum
beta-lactamase (ESBL) production and increased quinolone
resistance have been detected in EAEC (Hebbelstrup Jensen
et al., 2014). In most cases, EAEC infections are self-limiting,
but, in persistent cases, antibiotic use can be deemed necessary.
Glandt et al. investigated the clinical response to ciprofloxacin
against a placebo treatment, and found that patients treated
with ciprofloxacin had significant reductions in duration of
diarrhea compared with controls (Glandt et al., 1999). This, and
other studies, have suggested that fluoroquinolones, especially
ciprofloxacin, may be the most effective antibiotic when
treating EAEC infections (Cennimo et al., 2007). Unfortunately,
resistance toward ciprofloxacin in EAEC strains has been
reported in several studies (Hebbelstrup Jensen et al., 2014), and
with the evidence of increasing resistance emerging in EAEC, in
general, as well as other pathogens, it is important to investigate
this development continuously.
In this study, we investigated EAEC in diarrheal cases, and
determined its virulence in the Danish adult population. This
is the first time EAEC strains are characterized in adult Danish
patients and clinical symptoms are described. Furthermore, we
looked into the effect of antibiotic treatment on the duration
of EAEC-induced diarrhea, and determined the antibiotic
resistance of the clinical EAEC isolates.
MATERIALS AND METHODS
Study Population
Healthy controls: Asymptomatic carriage of EAEC in the gut of
the Danish population was examined in stool samples collected
from healthy individuals. Totally, 55 recruits submitted a stool
sample and a questionnaire, including questions of antibiotic
usage, in conjunction with a general health examination
(Frøkjaer Jensen and Hammerum, 2008). The median age of the
recruits was 33 years. Participation in the study was voluntary
and written informed consent was required. An additional 103
healthy controls were recruited from employees and students
from university settings in Copenhagen, where members of
the research team explained the purpose of the study and
received written informed consent prior to submission of a stool
sample and a questionnaire. The exclusion criteria were use of
antibiotics or reports of a diarrheal episode 14 days prior to stool
sampling. All controls were screened for the presence of EAEC by
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polymerase chain reaction (PCR) targeting the genes aatA, aggR,
and aaiC, as described in the section “EAEC Screening.”
Diarrheal cases: The study was conducted in the period
from 2011 to 2014. The EAEC were investigated in stool
samples from Danish patients with diarrhea, who had either
visited their general practitioner (GP) or were hospitalized,
and had submitted a stool sample for microbiological analysis
in one of the three Departments of Clinical Microbiology
(DCM) that participated in the study [Statens Serum Institut
(SSI), Hvidovre Hospital, and Slagelse Hospital]. At Hvidovre
Hospital and Slagelse Hospital, only patients suffering from
travelers’ diarrhea were investigated for the presence of EAEC.
Therefore, to investigate the true prevalence of EAEC from
all patients testing EAEC-positive, an assessment of the
annual/seasonal distribution of EAEC in stool samples submitted
for microbiological analysis for enteric pathogens at Statens
Serum Institut was performed for the period between June 2011
and June 2012. At this unit, all categories of diarrhea were
investigated for EAEC. A total of 436 patients, with a median
age of 34 years, were included in the study. Patients suffering
from diarrhea lasting longer than 90 days were excluded due
to sampling at a late stage in diarrheal episodes and possible
recall bias. To represent each patient, only one EAEC strain
was included for analysis. Through questionnaires, the patients
provided information concerning: duration and type of diarrhea,
foreign travel within the previous 2 months, and the use of
antibiotics or probiotics within the previous 14 days. The
patients were interviewed by phone by a medical doctor or
were contacted by e-mail using the same questionnaire. Follow-
up was performed for a group of EAEC-positive patients, 3–6
months after initial contact, to assess their current health status
and investigate if any possible differential diagnosis to diarrhea
and gastrointestinal disease other than EAEC (e.g., inflammatory
bowel disease, lactose intolerance, etc.) had emerged.
Microbiological Analysis
Stool samples underwent primary microbiological analysis at
the participating Departments of Microbiology. This included
microscopy for the enteric parasites Blastocystis hominis, Giardia
intestinalis, and Entamoeba spp. and PCR for Cryptosporidium
spp., G. intestinalis, Entamoeba spp., and Dientamoeba fragilis.
Stool sample material was suspended in growth medium and
cultured on the SSI selective enteric medium (Blom et al., 1999),
and modified charcoal cefoperazone deoxycholate agar medium
(SSI) (Hutchinson and Bolton, 1984), identifying Salmonella spp.,
Campylobacter spp., Yersinia spp., Shigella spp., Vibrio spp., Cl.
difficile, Aeromonas spp., and diarrheagenic E. coli. At least five E.
coli colonies showing different morphologies were screened by
using PCR to identify the following E. coli pathotypes: EAEC,
AEEC, ETEC, VTEC, EPEC, and EIEC (Persson et al., 2007;
Boisen et al., 2012).
EAEC Screening
The EAEC strains were identified by targeting the genes aatA,
aggR, and aaiC by multiplex PCR. Patients with EAEC-positive
stool samples, in the age of 18 and older, who spoke Danish and
lived in Denmark, were eligible for inclusion in this study. The
EAEC stock cultures were frozen at−80◦C in Luria-Bertani broth
(LB, Sigma Aldrich) containing 10% (-vol/vol-) glycerol. Bacteria
were cultivated in Dulbecco’s Modified EagleMedium containing
4.5 g/L D-Glucose (DMEM-HG, GibcoTM) for activation of
virulence genes or LB for 16–18 h at 37◦C, shaking at 180 rpm.
Initial identification for EAEC was performed at the
Departments of Clinical Microbiology at Slagelse Hospital
and Hvidovre Hospital by PCR targeting the aggR gene. The
EAEC-positive strains were forwarded to the Danish National
Reference Center for Escherichia and Klebsiella at SSI for further
characterization as described later. To diagnose EAEC, the genes
aap (dispersin protein), aatA (dispersin transporter protein),
aggR (transcription activator), and aaiC (secreted protein) were
targeted by PCR and DNA hybridization (Boisen et al., 2012).
Detection of two of these genes was considered diagnostic of
EAEC.
Characterization of EAEC Strains
For colony hybridization to detect genes aggR, aatA, and aaiC,
bacteria were grown overnight on a blue agar plate (SSI) and
then transferred to a Hybond-N+ nylon membrane (Amersham
Pharmacia Biotech) placed on a heart infusion agar plate
containing glucose (SSI). The digoxigenin-labeled probes had
previously been described by Boisen et al. (2008) and the DNA-
colony hybridization was modified from Struve et al. (2003).
Further characterization of the EAEC strains was performed
by additional PCR, targeting the genes sat, sepA, pic, sigA, pet,
astA, aap, agg3/4C, agg3A, aafA, aggA, agg4A, and agg5A as
previously described (Boisen et al., 2012; Jønsson et al., 2015)
with modifications. The characterization involved detection of
the SPATEs including sat (secreted autotransporter toxin), sepA
(Shigella extracellular protein), pic (serine protease precursor),
sigA (IgA protease homolog), pet (plasmid encoded protein), and
the astA gene, (EAEC heat-stable toxin). Furthermore, included
in the characterization were aap (dispersin) and aggA (fimbrial
subunit for AAF/I), aafA (fimbrial subunit for AAF/II), agg3A
(fimbrial subunit for AAF/III), agg3/4C (usher for AAF/III-
IV), agg4A (fimbrial subunit for AAF/IV), and agg5A (fimbrial
subunit for AAF/V).
Multiplex (QIAGEN, Copenhagen, Denmark) and singleplex
amplifications (Maxima Hot Start PCR master mix, Thermo
Scientific Inc.) were performed according to the manufacturer’s
instructions, with annealing temperatures at 57◦C and 1min
annealing. The PCR products were separated in 2% agarose gels
and run for 1–1.5 h at 100V.
Susceptibility Testing
Susceptibility toward antimicrobial agents was investigated by
using the tablet diffusion method according to the Clinical
and Laboratory Standards Institute, CLSI, guidelines [(Clinical
Laboratory Standards Institute (CLSI), 2011)], where 0.5
McFarland standard on Müeller-Hinton II agar plates (BBLTM,
US) were used. The EUCAST breakpoints (EUCAST.org, 2017)
using the Neo-SensitabsTM (Rosco Diagnostica A/S, Taastrup,
Denmark) were used for the following agents: sulfamethoxazole
64 mg/L (ECOFF value), trimethoprim 2 mg/L, ciprofloxacin
0.064 mg/L, tetracycline 8 mg/L, meropenem 0.125 mg/L,
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azithromycin 8 mg/L, nalidixic acid16 mg/L, cefotaxime 0.25
mg/L, chloramphenicol 6 mg/L, tigecycline 0.5 mg/L, ceftazidime
0.5 mg/L, colistin 2 mg/L, ampicillin 8 mg/L, and gentamicin 2
mg/L. Multidrug resistance was defined as acquired resistance
toward three or more antibiotics from different antibiotic classes
tested (Magiorakos et al., 2012).
Ethics
This study has been approved by The Danish National
Committee on Health Research Ethics, protocol number [H-
A-2009-066]. Written informed consent was obtained from the
study participants. The study was approved by the Danish Data
Protection Agency protocol number [2010-41-5405].
The Scientific Ethics Committee for the Copenhagen and
Frederiksberg municipalities approved the protocol prior to the
investigation of the recruits (KF 01-006/02).
Statistics
We utilized the classification and regression tree (CART)
Pro Version 6.0 (Salford Systems) software inputting factors
of interest as binary (present/absent, yes/no) independent
predictive variables along with a continuous “factor total” that
was a sum of all factors. We performed a CART analysis using the
likelihood ratio tests to identify statistically significant branching
points between specific EAEC virulence genes and duration
of diarrhea. We present a CART tree, where we treat it as a
categorical construct distinguishing between short-term diarrhea
(STD) (≤7 days) and long-term diarrhea (LTD) (≥14 days),
respectively. Odds ratios were calculated for each individual
EAEC gene in the group of adults with STD and LTD provided
with a 95% confidence interval and p-values, by using Pearson
X2. The T-tests and themultiple linear regression were performed
in the statistical computing environment R (2017), R Core Team
(2017), R: A language and environment for statistical computing,
R Foundation for Statistical Computing, Vienna, Austria. URL
https://www.R-project.org/.
RESULTS
Study Population
To investigate the rate of asymptomatic carriage of EAEC in
the intestinal tract of the Danish population, we examined stool
samples collected from 158 healthy individuals. Exclusion criteria
were use of antibiotics or reports of a diarrheal episode 14 days
prior to stool sampling. Only 2 healthy controls were found
positive for EAEC (1.2%).
The annual prevalence of EAEC in patients with diarrhea was
determined in a 1-year period from 2011 to 2012, where 10,036
diarrheal stool samples were submitted for microbiological
examinations at SSI (no selection). The EAEC was detected in
470 (4.8%) of the stool samples, which accounted for ∼4.6% of
the patients.
During the full study period from 2011 to 2014, 436 EAEC-
positive patients were interviewed and deemed eligible for
inclusion in the study. Between the 436 EAEC-positive patients,
a total of 737 samples were collected at the participating units.
In this study, only one sample was included per patient. In
49 patients, at least one other enteric pathogen was identified.
The majority of the co-infections patients were seen to suffer
from travelers’ diarrhea (98%), and co-infections in this patient
category has previously been described to occur frequently
(Lääveri et al., 2014). The patients, who were co-infections,
were excluded from further statistical analysis, as we wanted
to investigate the clinical manifestations associated with EAEC
only. Totally, 34 patients reported diarrheal duration to be
higher than 90 days. These were excluded due to possible
comorbidities and/or recall bias. Finally, 66 patients were
excluded since the duration of diarrhea was unknown. A total of
287 patients were eligible for inclusion in the statistical analyses
(Figure 1).
Follow-up was conducted after 3–5 months for 75 of the 436
EAEC-infected patients, where five patients had been diagnosed
with gastrointestinal diseases prior to EAEC infection. Herein,
two patients had Crohn’s disease, two patients had irritable
bowel disease, and one patient had ulcerative colitis. Within
the follow-up period after EAEC infection, two patients were
diagnosed with irritable bowel syndrome. Sixteen from the 76
patients available for follow-up had been referred to a specialist in
gastroenterology. Of the 16 patients, 12 patients had undergone
endoscopy to investigate the cause of diarrhea, with no signs of
pathology a part from minor enteric inflammation.
FIGURE 1 | Flow diagram showing the patients included for analysis.
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TABLE 1 | Characteristics of EAEC-positive patients.
No. of patients Median duration of diarrhea in days p-value Confidence interval
POPULATION
Male 95 14 0.73 [−5.43; 3.80]
Female 192 14
DURATION OF DIARRHEA
Short-term (≤7 days) 90
Intermediate (8–14 days) 83
Long-term (>14 days) 114
Ongoing 51
DIARRHEAL TYPE
Watery £ 256  0.42# [−3.58;8.35]
Mucoid 140 0.31 [−1.89;18.88]
Mixed watery and mucoid 140
Bloody 43 0.22 [−1.50;6.60]
Travelers’ diarrhea 265 14 0.38 [−5.31; 13.58]
Nontravelers’ diarrhea 22 14
Co-infection 49 10 0.00 [1.73;7.94]
No co-infection 287 14
USE OF ANTIBIOTICS
Yes 76 12 0.60 [−5.51;3.21]
No 186 14
Not answered 25
USE OF ANTIBIOTICS
Ciprofloxacin
Yes 32 14.5 0.86β [−7.61;6.39]
No 320 13
Penicillins 11
Metronidazole 4
Azithromycin 2
Doxycycline 2
Gentamycin 1
Tazocin 1
Tetracycline 1
Nitrofurantoin 1
Other 4
Unknown 10
Several antibiotics used 11
USE OF OTHER DIARRHEAL MEDICATION
Yes 129 14 0.22# [−5.88; 1.34]
No 158 12
Lopamide 68 14
Probiotics
Paraghurt 33 13
Idoform 10 14.5
Other 17 14
£Several types of diarrhea were reported from the majority of the patients. The majority of diarrheal cases was mixed and the contribution to the duration of diarrhea could not be
individualized.
#The p-values and confidence intervals for bloody, mucoid, and watery diarrhea are from a multiple regression using these three constructs as predictors of diarrhea length. The same
analysis was performed for “Use of other diarrheal medication” compared with no usage of any medication.
βPatients with use of ciprofloxacin compared with patients without any use of antibiotics.
EAEC-Associated Symptoms
The median age of the 287 interviewed EAEC-positive patients
was 34 years. The STD (≤7 days) was reported from 90 patients
and intermediate duration of diarrhea (8–14 days) was reported
from 83 patients; LTD lasting more than 14 days was reported
from 114 patients. The episode of diarrhea had not ended in
51 patients at the time of the interview. The median duration
of diarrhea was 14 days. Watery diarrhea was seen to be highly
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prevalent in patients infected with EAEC. In total, 256 patients
(89%) reported watery diarrhea, 140 patients (49%) mucoid
diarrhea, mixed watery, and mucoid diarrhea was reported in
140 patients, and 43 patients (15%) reported bloody diarrhea
(Table 1). The median of the maximum number of diarrheal
outputs per day was 7. Totally, 16 (6%) patients had been
admitted to the hospital.
Travelers’ Diarrhea
The majority of the EAEC-positive patients suffered from
travelers’ diarrhea (n = 264, 92%). However, two of the
participating units only investigated EAEC in cases of travelers’
diarrhea. Various destinations were reported from the patients,
who suffered from travelers’ diarrhea. Totally, 59 patients
had visited Egypt, 21 had been to Turkey, 31 to India, and
13 to Thailand. Tanzania, Germany, Cuba, and Nepal were
each visited by 5 patients. Multiple travel destinations were
reported from 57 patients. Several other travel destinations
were reported, but with very few visits from patients. The
duration of travelers’ diarrhea was not seen to be longer
compared with patients without reports of traveling (p =
0.38).
Treatment of EAEC
Use of antibiotics was investigated as a predictor for the
duration of EAEC-induced diarrhea. It was seen that the
duration of diarrhea was not shortened by using antibiotics
p = 0.6 (CI [−5.51; 3.21]). Since ciprofloxacin has been
recommended for the treatment of EAEC (Glandt et al., 1999),
we assessed the effect of antibiotics on diarrheal persistence.
We did not observe a significant reduction of diarrhea by
ciprofloxacin (p = 0.86, CI [−7.61; 6.39]). The usage of
other antibiotics (median duration of diarrhea 13 days) was
compared with the use of ciprofloxacin (median duration
14.5 days) and was not statistically significant, p = 0.53 (CI
[−6.71; 3.53]). As a large part of the patients investigated
suffered from traveler’s diarrhea, it was investigated if the
duration of EAEC-induced diarrhea was affected by consumption
of probiotics and or use of other antidiarrheal drugs; no
effects on the duration of diarrhea were seen from taking
these over-the-counter remedies p = 0.22 (CI [−5.88; 1.34])
(Table 1).
Co-infections
In our study, 49 patients (17%) were infected with EAEC
and an additional microorganism. All, but one patient with
co-infections was seen to suffer from travelers’ diarrhea.
The majority of the enteropathogens in co-infections were
conventional microorganisms detected in cases of travelers’
diarrhea. The AEEC was the most frequently detected pathogen
in 18/49 EAEC cases with mixed pathogens, followed by
ETEC, which was found among 13 EAEC cases. The highly
prevalent enteropathogen in travelers’ diarrhea Campylobacter
spp. was found in 4 cases (Table 2). When different predictors
were investigated for the duration of diarrhea, co-infections
patients were seen to have a significant shorter duration
TABLE 2 | Distribution of enteropathogens in co-infections.
Microorganisms in EAEC
co-infections
Number of co-infected patients
(N = 49)
BACTERIA
AEEC 18
ETEC 13
Campylobacter spp. 4
EPEC 2
Aeromonas spp. 2
VTEC 1
Yersinia enterocolitica 1
Clostridium difficile 1
Shigella spp. 1
PARASITES
Blastocystis hominis 4
Entamoeba spp. 2
Giardia lamblia 2
Cryptosporidium spp. 1
VIRUS
Norovirus 2
From the 49 co-infected patients five were co-infected with several enteropathogens.
compared with patients only infected with EAEC, p =
0.00.
Distribution of EAEC Virulence Genes
Totally, 250 randomly selected stool samples of the 287,
which had tested positive for the presence of aggR at either
Hvidovre or Slagelse Hospital, were chosen for virulence
gene characterization. However, by subsequent PCR and DNA
hybridization, only 189 of the 250 samples were confirmed to
have at least one of the EAEC genes tested for (aggR, aatA, aaiC,
aap). In this study, EAEC was defined as testing positive for at
least two of the previously mentioned four genes. Therefore, of
the 189 isolates, 26 strains were excluded. Finally, nine isolates
were excluded due to missing information in the questionnaires
regarding duration of diarrhea. In total, 154 clinical EAEC
isolates were eligible for further PCR characterization.
Assessing the prevalence of virulence genes in cases of STD
and LTD, no significant differences in odds ratio between the
two groups were observed. Table 3 presents the distribution of
EAEC genes in strains isolated from adults with either STD or
LTD (intermediate duration was not included, n= 19). In the 135
strains, the most abundant genes observed were aggR and aap at
97.8% (n = 132) and aatA at 88.9% (n = 120). The toxin gene
most commonly found in the total number of strains was the Pic
toxin (pic) present in 75.6% (n = 102) of the strains. The EAST1
toxin (astA) was observed in 34.8% (n = 47) of the total number
of strains, and the sepA toxin (sepA) was found in 34.1% (n =
46) of the total number of strains. Of the fimbrial genes, AAF/I-
AAF/V, AAF/I (aggA) was the most abundant in 22.2% (n = 30,
total 135) followed by AAF/IV (agg4A) at 18.5%, AAF/III (agg3A)
at 17%, AAF/V (agg5A) at 16.3%, and finally, AAF/II (aafA) at
12.6%.
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FIGURE 2 | The CART tree analysis for assessing combinations of genotypic factors most strongly associated with long-term diarrhea. We considered all genotypic
assays performed: aatA, aggR, aaiC, aap, sat, sepA, pic, sigA, pet, astA, agg3/4C, agg5A, agg3A, aafA, aggA, agg4A, and the virulence factor score (VFS). Each
branch of the CART tree ends in a terminal node (red box), and each terminal node is defined by the presence or absence of a factor such as a gene or VFS. STD,
short-term diarrhea; LTD, long-term diarrhea.
FIGURE 3 | Patterns of antibiotic resistance in 137 clinical EAEC isolates.
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TABLE 3 | Distribution of EAEC virulence factors in cases of STD and LTD.
EAEC STD cases (n = 53) LTD cases (n = 82) Total (N = 135)
Virulence gene No. (%) No. (%) No. (%) Odds Ratio χ2 (Pearson) P-value (Pearson)
aatA 48 (90.6) 72 (87.8) 120 (88.9) 0.75 0.25 0.62
aggR 52 (98.1) 80 (97.6) 132 (97.8) 0.77 – –
aaiC 40 (75.5) 64 (78.0) 104 (77.0) 1.16 0.12 0.73
aap 52 (98.1) 80 (97.6) 132 (97.8) 0.77 – –
sat 24 (45.3) 43 (52.4) 67 (49.6) 1.33 0.66 0.42
sepA 17 (32.1) 29 (35.4) 46 (34.1) 1.16 0.16 0.69
pic 39 (73.6) 63 (76.8) 102 (75.6) 1.19 0.18 0.67
sigA 3 (5.7) 8 (9.8) 11 (8.1) 1.80 - -
pet 7 (13.2) 17 (20.7) 24 (17.8) 1.72 1.25 0.26
astA 14 (26.4) 33 (40.2) 47 (34.8) 1.88 2.71 0.10
agg3/4C 27 (50.9) 40 (48.8) 67 (49.6) 0.92 0.06 0.81
agg5A 9 (17.0) 13 (15.9) 22 (16.3) 0.92 0.03 0.86
agg3A 10 (18.9) 13 (15.9) 23 (17.0) 0.81 0.21 0.65
aafA 6 (11.3) 11 (13.4) 17 (12.6) 1.21 0.13 0.72
aggA 12 (22.6) 18 (22.0) 30 (22.2) 0.96 0.01 0.92
agg4A 9 (17.0) 16 (19.5) 25 (18.5) 1.19 0.14 0.71
Isolates from 19 patients with intermediate duration of diarrhea were excluded, i.e., no belonging to either short-term diarrhea (STD) ≤7 days or long-term diarrhea (LTD) >14 days.
However, the virulence profile of the isolates was determined and found similar to that of the other two (data not shown). p < 0.05 is significant.
CART Analysis—Assessing Combinations
of Multiple EAEC Virulence Genes
To consider the combination of virulence factors in association
with STD and LTD, we performed a CART analysis. We
considered all genotypic assays performed, and interrogated
the association with the diarrheal duration. Of the 135 clinical
EAEC isolates, 53 strains were isolated from adults with STD
and 82 strains from adults with LTD. The CART analysis
suggested that the presence of the astA gene, regardless
of the presence or absence of any other scored genotype,
showed an association with LTD. When lacking the astA
gene, a high virulence factor score (VFS > 9) appeared
to be associated with LTD, and if the VFS < 9, the
toxin genes sigA and pet showed an association with LTD
(Figure 2).
Antibiotic Resistance in EAEC Isolates
Susceptibility testing toward antibiotics was performed for
137 of the 154 clinical EAEC isolates (17 isolates were not
recovered). Overall, we observed a high level of resistance
towards antibiotics (Figure 3). More than 50% of the strains
were resistant toward ampicillin (n = 83) (61%), trimethoprim
(n = 79) (58%), and sulfamethoxazole (n = 73) (53%), but
high resistance levels were also observed for tetracycline (n =
64) (47%), ciprofloxacin (n = 47) (34%), and nalidixic acid
(n= 46) (34%).
The MDR, defined as acquired resistance toward three or
more antibiotics from different antibiotic classes tested, was
observed in 58% (n = 80) of the strains (Figure 3). We observed
no significant differences between the investigated parameters in
non-MDR and MDR strains (Table 4).
DISCUSSION
In our study, asymptomatic carriage of EAEC was rare, and from
158 healthy Danish adult controls, only two tested positive for
EAEC (1.2%). We have previously shown a 10.5% carriage of
EAEC in healthy Danish children (Hebbelstrup Jensen et al.,
2016). A high number of healthy carriers of EAEC have been
reported from studies conducted in children from the developing
world (Kotloff et al., 2012). The high prevalence of asymptomatic
carriage of EAEC in children has been explained by frequent
exposure to EAEC and to acquired immunity in regions with
reduced hygiene (Medina et al., 2010; Opintan et al., 2010).
Our finding suggests that asymptomatic carriage of EAEC is not
common in the Danish adult patients.
The duration of EAEC-induced diarrhea was seen to be
shortened in patients, who were co-infections. As EAEC is
generally considered to be noninvasive and of relatively low-
virulence compared with e.g., Salmonella spp., co-infections with
EAEC and an additional enteropathogen might be speculated to
cause a stronger activation of the immune system. Co-infections
with several enteric pathogens have previously been described
to elicit a higher level of inflammation mediators (Qadri et al.,
2002), which may result in faster eradication of enteropathogens.
A large proportion of the patients investigated for EAEC suffered
from traveler’s diarrhea, which, in several studies, has proved a
risk factor for infections with multiple pathogens (Paschke et al.,
2010; Lääveri et al., 2014). In our study, 265 of 287 patients (92%)
suffered from travelers’ diarrhea, and 48 were seen to be infected
with EAEC and an additional microorganism.
Totally, 135 clinical EAEC strains causing either STD or LTD
were examined by a multiplex PCR for the presence of virulence
genes. The most frequently detected virulence genes were aggR
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TABLE 4 | Characteristics of patients infected with antibiotic-resistant EAEC
strains.
Non-MDR EAEC
strains (N = 57)
MDR EAEC
strains (N = 80)
p-valuea
No. of patients (%) No. of patients (%)
DIARRHEAL DURATION
Short-term (≤7 days) 18 (32) 29 (36) 0.6
Intermediate (8–14 days) 6 (11) 9 (11) 1
Long-term (>14 days) 31 (54) 37 (46) 0.5
Unknown 2 (4) 5 (6) –
Antibiotic use 15 (26) 23 (29) 0.8
Ciprofloxacin 10 (18)* 10 (13)** 0.5
Other 5 (9) 13 (16) 0.3
Foreign travel 50 (88) 70 (88) 1
TRAVEL DESTINATIONS
Asia 19 (33) 34 (43) 0.3
Africa 12 (21) 24 (30) 0.3
Europe 6 (11) 2 (3) 0.07
South America 3 (5) 2 (3) 0.6
North America 2 (4) – –
Multiple destinations 9 (16) 8 (10) 0.5
aTwo-tailed Fisher Exact Probability Test. *10/10 had reports of foreign travel. **9/10 had
reports of foreign travel.
(transcriptional activator) and aap (dispersin protein) at 97.8%.
Compared with other studies (Jiang et al., 2002; Kahali et al.,
2004), we detected a higher frequency of these genes, which
could have two explanations: First, working with an optimized
PCR protocol allowing for better detection of EAEC genes.
Secondly, we required the presence of at least two EAEC genes,
potentially introducing strain selection bias. Of the AAFs, we
found that AAF/I (aagA) was the most prevalent at 22.2%, which
corresponds well with other studies (Boisen et al., 2012; Jønsson
et al., 2015). Of the toxin genes, we found pic to have the highest
prevalence (75.6%), followed by astA (34.8%) and sepA (34.1%).
A study by Boisen et al. found the sat gene to be the single-most
common gene (74.5%) in a large EAEC strain collection from
multiple countries. However, pic was detected in 63.6% of the
EAEC strains, and sepA in 38.2% of the EAEC strains (Boisen
et al., 2009). The SPATEs are extracellular proteases secreted by
bacteria and are thought to play an important role in secretory
diarrhea during EAEC infection (Hebbelstrup Jensen et al., 2014).
Therefore, it is not surprising that we observe a high frequency of
toxins in strains isolated from patients suffering from an EAEC
infection.
We assessed combinations of putative virulence factors by
employing the CART analysis, and this suggested that the toxin
astA was the virulence gene most strongly associated with LTD,
regardless of any of the other 16 genes scored. The astA gene
encodes the enterotoxin EAST-1, which is commonly detected
in EAEC strains, and has previously been associated with watery
diarrhea (Ménard and Daniel Dubreuil, 2002; Kaper et al., 2004).
Previously, we have described how the astA is important in
prolonged diarrhea in children (Hebbelstrup Jensen et al., 2017).
However, many commensal E. coli strains also harbor the EAST-
1 toxin, and it has, therefore, been suggested that additional
virulence factors are required to mediate diarrhea (Konno et al.,
2012). Among the astA-negative strains, it appeared that having
a VFS> 9 could be associated with persistent diarrhea, whereas a
VFS < 9 required the toxins sigA and pet for an association with
LTD. Overall, our CART analysis does not provide a clear picture
of a gene combination associated with LTD, but the importance
of the toxin genes and a high VFS were observed, which
correlates with the general belief that multiple virulence factors
are important for EAEC pathogenesis (Hebbelstrup Jensen et al.,
2014).
We detected high levels of antibiotic resistance among
137 EAEC strains isolated from Danish adults suffering from
diarrhea. Previously, we have detected MDR among 35% of
EAEC strains in Danish children in daycare (Hebbelstrup
Jensen et al., 2016), and in 38% of EAEC strains isolated from
Danish children with diarrhea (Hebbelstrup Jensen et al., 2017).
Surprisingly, in this study, we detected a high level of resistance
toward ciprofloxacin (34%), which is still one of the most
frequently used antimicrobials for diarrhea (Kong et al., 2015). In
earlier studies, EAEC was described as usually being susceptible
to ciprofloxacin (Okeke and Nataro, 2001), and this increase
in resistance is a serious cause for concern and needs to be
considered when treating cases of travelers’ diarrhea. In our study
period from 2011 to 2014, the ciprofloxacin-resistance levels in
invasive E. coli isolates from patients in Denmark were stable
between 12 and 14%. The same tendency was observed for E. coli
urine isolates from patients in Danish hospitals (Borck Høg et al.,
2016). This could indicate that there is a high antibiotic resistance
in EAEC isolates as well. However, we also detected a high degree
of MDR EAEC strains (58%), and the majority of the strains
were isolated from patients with reports of foreign travel (88%),
indicating that we might be introducing MDR strains into the
Danish population when returning from traveling, especially in
Asia and Africa. A Spanish study from 2009 found high levels of
resistance in EAEC strains isolated from travelers. In particular,
they report a high percentage of resistance to quinolones in
EAEC strains isolated from travelers to North Africa and India.
They also reported an increase in antibiotic resistance between
two time periods (1994–97 and 2001–04) (Mendez Arancibia
et al., 2009). The importance of the MDR EAEC strains has been
reflected in a community outbreak of urinary tract infection in
Denmark by ST10 O78:H10 EAEC clone (Olesen et al., 2012; Boll
et al., 2013).
The high number of MDR EAEC strains detected in our
study is a cause for concern. A high number of MDR EAEC
strains has previously been reported from studies conducted
in Asia (75.8%) (Chattaway et al., 2017) and Africa (61%)
(Seidman et al., 2016), but, as seen in our study, it also comprises
industrialized countries. Colonization with bacterial strains with
a high level of resistance in the intestinal tract of children, who
are naïve to antibiotic treatment, was discovered (Sydenham
et al., 2017). This indicates a considerable sharing of enteric
microorganisms in the community (Johnson et al., 2008), where
a host susceptible to EAEC infection can have very limited
treatment options. Host genetic susceptibility to acquire an
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 September 2018 | Volume 8 | Article 306
Hebbelstrup Jensen et al. Multidrug Resistance in EAEC Diarrheal Cases
EAEC infection has been discussed previously (Jiang et al., 2003;
Mohamed et al., 2011), and a high rate of asymptomatic carriage
of EAEC was reported in other studies (Nüesch-Inderbinen et al.,
2013). As EAEC strains are believed to consist of pathogenic
as well as nonpathogenic strains (Hebbelstrup Jensen et al.,
2014), the clinical decision whether to treat a person or not
with EAEC is difficult. In addition, the clinicians may be forced
to submit the patient suffering from diarrhea to additional
medical examinations to diagnose the cause of diarrhea, since
the individual pathogenic significance of EAEC continues to
be discussed. Ciprofloxacin was ineffective toward limiting the
duration of diarrhea in patients in our study. Although this
drug has previously shown to have a therapeutic effect in EAEC-
associated diarrhea (Glandt et al., 1999), it is not recommendable
for treating EAEC infection, especially considering the high level
of resistance in travelers’ diarrhea.
CONCLUSION
The EAEC was detected only in two out of 158 healthy adult
controls (1.2%), and is, therefore, not expected to be common in
the healthy Danish population. The majority of EAEC-infected
patients suffered from long-lasting diarrhea >14 days and by
follow-up, we discovered that 16 patients had undergone invasive
examinations with e.g., endoscopy for examinations of the cause
of diarrhea with no signs of pathology. The astA gene and a high
VFSwere both found to be important in the development of long-
lasting diarrhea. Multidrug resistance in EAEC strains was found
in a surprisingly high number in Danish patients suffering from
diarrhea. Assessing the types of treatment and effect of treatment
on duration of diarrhea, it was seen that antibiotics, especially
ciprofloxacin, was ineffective toward limiting the duration of
diarrhea in EAEC cases. Therefore, it is suggested that antibiotics
should be used with care only in predisposed individuals or in
patients with severe comorbidity.
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